Security key
76155X100
Revolution Medicines, Inc. - Common Stock (RVMD)
CUSIP: 76155X100
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 199,316,245
- Total 13F shares
- 170,577,261
- Share change
- +1,182,120
- Total reported value
- $7,735,337,873
- Put/Call ratio
- 238%
- Price per share
- $45.35
- Number of holders
- 252
- Value change
- +$69,484,732
- Number of buys
- 141
- Number of sells
- 83
Report period
Q3 2024
Institutions
252
Top holders
10
RVMD full security history
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Revolution Medicines, Inc. SEC filings
Revolution Medicines, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 76155X100
Recent filing periods:
Top shareholders of RVMD - Revolution Medicines, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
7.2%
|
14,378,297
|
$558,021,707 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
6.9%
|
13,660,196
|
$530,152,207 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.7%
|
13,408,713
|
$520,392,152 | — | 30 Jun 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
3.8%
|
7,569,090
|
$293,756,383 | — | 30 Jun 2024 | |
| Nextech Invest Ltd. |
13F
|
Company |
3.2%
|
6,296,740
|
$244,376,479 | — | 30 Jun 2024 | |
| BVF INC/IL |
13F
|
Company |
3%
|
5,981,212
|
$232,130,838 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
2.8%
|
5,625,856
|
$218,339,471 | — | 30 Jun 2024 | |
| Alphabet Inc. |
13F
|
Company |
2.7%
|
5,307,075
|
$205,967,580 | — | 30 Jun 2024 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
2.6%
|
5,259,089
|
$204,105,244 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.5%
|
5,071,068
|
$196,808,149 | — | 30 Jun 2024 | |
| Bellevue Group AG |
13F
|
Company |
2.5%
|
5,029,100
|
$195,179,371 | — | 30 Jun 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2.3%
|
4,640,218
|
$180,069,308 | — | 30 Jun 2024 | |
| Casdin Capital, LLC |
13F
|
Company |
2.2%
|
4,406,875
|
$171,030,819 | — | 30 Jun 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
2.1%
|
4,279,464
|
$166,085,998 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
3,335,656
|
$129,479,405 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.7%
|
3,290,791
|
$127,715,599 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.6%
|
3,115,575
|
$120,915,467 | — | 30 Jun 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.6%
|
3,090,073
|
$119,925,733 | — | 30 Jun 2024 | |
| a16z Capital Management, L.L.C. |
13F
|
Company |
1.4%
|
2,748,523
|
$106,670,178 | — | 30 Jun 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
1.2%
|
2,363,584
|
$91,730,695 | — | 30 Jun 2024 | |
| Holocene Advisors, LP |
13F
|
Company |
1.1%
|
2,203,474
|
$85,516,826 | — | 30 Jun 2024 | |
| NORGES BANK |
13F
|
Company |
0.93%
|
1,848,647
|
$71,745,990 | — | 30 Jun 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.74%
|
1,472,290
|
$57,139,586 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.73%
|
1,448,095
|
$56,200,566 | — | 30 Jun 2024 | |
| Logos Global Management LP |
13F
|
Company |
0.6%
|
1,200,000
|
$46,572,000 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.59%
|
1,180,016
|
$45,796,421 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.56%
|
1,109,684
|
$43,066,836 | — | 30 Jun 2024 | |
| Artal Group S.A. |
13F
|
Company |
0.51%
|
1,015,776
|
$39,422,267 | — | 30 Jun 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
0.5%
|
997,455
|
$38,711,229 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.5%
|
995,489
|
$38,634,938 | — | 30 Jun 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.47%
|
943,195
|
$36,605,398 | — | 30 Jun 2024 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.46%
|
914,003
|
$35,472,456 | — | 30 Jun 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.43%
|
856,178
|
$33,228,268 | — | 30 Jun 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.41%
|
816,055
|
$31,671,095 | — | 30 Jun 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
0.38%
|
755,000
|
$29,301,550 | — | 30 Jun 2024 | |
| Finepoint Capital LP |
13F
|
Company |
0.37%
|
729,464
|
$28,310,498 | — | 30 Jun 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.33%
|
650,826
|
$25,258,557 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.32%
|
645,253
|
$25,042,259 | — | 30 Jun 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.28%
|
554,334
|
$21,512,699 | — | 30 Jun 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.27%
|
542,601
|
$21,058,345 | — | 30 Jun 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.26%
|
519,305
|
$20,154,273 | — | 30 Jun 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.26%
|
511,894
|
$19,866,606 | — | 30 Jun 2024 | |
| MIC Capital Management UK LLP |
13F
|
Company |
0.26%
|
508,569
|
$19,737,563 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.23%
|
455,132
|
$17,663,673 | — | 30 Jun 2024 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.23%
|
455,099
|
$17,662,392 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.2%
|
400,567
|
$15,546,005 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.2%
|
390,583
|
$15,158,526 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.19%
|
380,594
|
$14,770,853 | — | 30 Jun 2024 | |
| Mass General Brigham, Inc |
13F
|
Company |
0.17%
|
338,191
|
$13,125,193 | — | 30 Jun 2024 | |
| First Turn Management, LLC |
13F
|
Company |
0.17%
|
329,519
|
$12,788,632 | — | 30 Jun 2024 |
Institutional Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q3 2024
As of 30 Sep 2024,
Revolution Medicines, Inc. - Common Stock (RVMD) was held by
252 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
170,577,261 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP, FARALLON CAPITAL MANAGEMENT LLC, BAKER BROS. ADVISORS LP, Nextech Invest Ltd., JANUS HENDERSON GROUP PLC, FMR LLC, Paradigm Biocapital Advisors LP, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
254
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
221
Q3 2024 holders
252
Holder diff
31
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.